5-HT1D receptor agonists are pharmaceutical drugs for the treatment of migraine. They include:
Triptans (which additionally act as 5-HT1B receptor agonists)
Ergotamine (which also has other mechanisms of action)
Dihydroergotamine, a derivative of the former
Alniditan